Politics1 min read

STAT+: White House pulls nomination of Heidi Overton to lead FDA

By · Via STAT Health · Published by Everything Blog

In short

The Trump administration decided to abandon Heidi Overton's bid to become commissioner of the Food and Drug Administration. The sudden retreat was prompted by indications that she lacked sufficient support from Republican lawmakers on the Senate health committee. A formal panel vote on her selection had been set to take place on Wednesday. Overton, a preventive care doctor, had previously worked in the Trump White House.

Key points

  • Concerns over insufficient support from Republican members on the Senate health panel tri…: Concerns over insufficient support from Republican members on the Senate health panel triggered the withdrawal.
  • Heidi Overton is a preventive care doctor who previously served in the Trump White House.: Heidi Overton is a preventive care doctor who previously served in the Trump White House.
  • The administration abandoned the confirmation effort following an initial report by Axios…: The administration abandoned the confirmation effort following an initial report by Axios on Tuesday evening.

Sources checked by our analysis pipeline: 1

WASHINGTON — The Trump administration is pulling its nominee to lead the Food and Drug Administration, Heidi Overton, according to a White House official and a source close to Overton.

The decision follows concerns that Overton, a preventive care doctor who previously served in the Trump White House, lacked sufficient support from Republicans on the Senate’s health panel, which had been expected to vote on her nomination Wednesday.

The news was first reported by Axios on Tuesday evening.

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

Politics